Levothyroxine Sodium Tablets USP 150 mcg
Macleods Pharma recalls Levothyroxine Sodium 150 mcg tablets (NDC 33342-401-44) nationwide due to subpotency.
Do not use this medication. Contact your pharmacy or healthcare provider immediately to obtain a replacement supply from an unaffected lot. Do not stop taking levothyroxine without medical guidance.
Recall at a glance
- Quantity recalled
- 1315 bottles
Why it was recalled
Macleods Pharma USA is recalling Levothyroxine Sodium Tablets USP 150 mcg (1000-tablet bottles, NDC 33342-401-44) distributed nationwide due to subpotency. Affected tablets may contain less active ingredient than labeled, potentially resulting in inadequate thyroid hormone replacement therapy.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Levothyroxine Sodium Tablets USP
- Strength
- 150 mcg
- NDC / UPC
- NDC 33342-401-44
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Editorial summary by Recall Canary · summary updated 2026-04-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification